Eleni A. Rekka

2.4k total citations
109 papers, 2.0k citations indexed

About

Eleni A. Rekka is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Eleni A. Rekka has authored 109 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Organic Chemistry, 25 papers in Molecular Biology and 24 papers in Pharmacology. Recurrent topics in Eleni A. Rekka's work include Synthesis and biological activity (19 papers), Free Radicals and Antioxidants (19 papers) and Pharmacogenetics and Drug Metabolism (15 papers). Eleni A. Rekka is often cited by papers focused on Synthesis and biological activity (19 papers), Free Radicals and Antioxidants (19 papers) and Pharmacogenetics and Drug Metabolism (15 papers). Eleni A. Rekka collaborates with scholars based in Greece, Cyprus and Norway. Eleni A. Rekka's co-authors include Panos N. Kourounakis, Angeliki P. Kourounakis, Panagiotis Theodosis‐Nobelos, Vassilis J. Demopoulos, Antonios Gavalas, Dimitrios Galanakis, Phaedra Eleftheriou, Aalt Bast, Christos Charitos and H. Timmerman and has published in prestigious journals such as Biochemistry, Biochemical Journal and Annals of the New York Academy of Sciences.

In The Last Decade

Eleni A. Rekka

106 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eleni A. Rekka Greece 24 775 523 345 310 229 109 2.0k
Panos N. Kourounakis Greece 25 658 0.8× 481 0.9× 392 1.1× 302 1.0× 202 0.9× 122 1.9k
Roberta Budriesi Italy 30 1.0k 1.3× 1.1k 2.0× 310 0.9× 203 0.7× 217 0.9× 154 2.7k
Tadigoppula Narender India 28 1.1k 1.4× 892 1.7× 391 1.1× 233 0.8× 119 0.5× 125 2.7k
Rafael Villalobos‐Molina Mexico 29 417 0.5× 859 1.6× 248 0.7× 233 0.8× 296 1.3× 96 2.4k
Majid Moridani United States 25 433 0.6× 724 1.4× 217 0.6× 217 0.7× 482 2.1× 44 2.1k
Zai‐Qun Liu China 30 1.3k 1.7× 881 1.7× 309 0.9× 330 1.1× 452 2.0× 114 2.8k
Milan Štefek Slovakia 28 493 0.6× 1.0k 1.9× 300 0.9× 276 0.9× 383 1.7× 134 3.1k
Lubomı́r Opletal Czechia 28 758 1.0× 723 1.4× 699 2.0× 606 2.0× 350 1.5× 100 2.2k
Isabelle Morel France 24 290 0.4× 784 1.5× 172 0.5× 368 1.2× 457 2.0× 102 2.6k
Fabio Fusi Italy 27 342 0.4× 928 1.8× 256 0.7× 147 0.5× 286 1.2× 112 2.0k

Countries citing papers authored by Eleni A. Rekka

Since Specialization
Citations

This map shows the geographic impact of Eleni A. Rekka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleni A. Rekka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleni A. Rekka more than expected).

Fields of papers citing papers by Eleni A. Rekka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleni A. Rekka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleni A. Rekka. The network helps show where Eleni A. Rekka may publish in the future.

Co-authorship network of co-authors of Eleni A. Rekka

This figure shows the co-authorship network connecting the top 25 collaborators of Eleni A. Rekka. A scholar is included among the top collaborators of Eleni A. Rekka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleni A. Rekka. Eleni A. Rekka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Theodosis‐Nobelos, Panagiotis & Eleni A. Rekka. (2025). Tyrosine and proline conjugated trolox, hydroxy-cinnnamic acid and diclofenac hybrids as strong hypolipidemic and anti-inflammatory agents.. Bioorganic & Medicinal Chemistry Letters. 122. 130194–130194. 4 indexed citations
3.
Theodosis‐Nobelos, Panagiotis & Eleni A. Rekka. (2024). The Antioxidant Potential of Vitamins and Their Implication in Metabolic Abnormalities. Nutrients. 16(16). 2740–2740. 11 indexed citations
4.
Theodosis‐Nobelos, Panagiotis, et al.. (2020). A Review on Vitamin E Natural Analogues and on the Design of Synthetic Vitamin E Derivatives as Cytoprotective Agents. Mini-Reviews in Medicinal Chemistry. 21(1). 10–22. 17 indexed citations
5.
Theodosis‐Nobelos, Panagiotis, et al.. (2015). Esters of some non-steroidal anti-inflammatory drugs with cinnamyl alcohol are potent lipoxygenase inhibitors with enhanced anti-inflammatory activity. Bioorganic & Medicinal Chemistry Letters. 25(22). 5028–5031. 21 indexed citations
6.
Theodosis‐Nobelos, Panagiotis, Malamati Kourti, Antonios Gavalas, & Eleni A. Rekka. (2015). Amides of non-steroidal anti-inflammatory drugs with thiomorpholine can yield hypolipidemic agents with improved anti-inflammatory activity. Bioorganic & Medicinal Chemistry Letters. 26(3). 910–913. 26 indexed citations
7.
Eleftheriou, Phaedra, et al.. (2011). Compounds against inflammation and oxidative insult as potential agents for neurodegenerative disorders. Medicinal Chemistry Research. 21(9). 2280–2291. 11 indexed citations
8.
Rekka, Eleni A. & Panos N. Kourounakis. (2010). Medicinal Chemistry of 2,2,4-Substituted Morpholines. Current Medicinal Chemistry. 17(29). 3422–3430. 20 indexed citations
9.
Rekka, Eleni A., et al.. (2006). Design and study of some novel ibuprofen derivatives with potential nootropic and neuroprotective properties. Bioorganic & Medicinal Chemistry. 15(2). 951–961. 24 indexed citations
10.
Rekka, Eleni A., et al.. (2005). Nitric oxide releasing derivatives of tolfenamic acid with anti-inflammatory activity and safe gastrointestinal profile. Bioorganic & Medicinal Chemistry. 13(23). 6485–6492. 20 indexed citations
11.
Galanakis, Dimitrios, Angeliki P. Kourounakis, Antonios Gavalas, et al.. (2005). Synthesis and pharmacochemical study of novel polyfunctional molecules combining anti-inflammatory, antioxidant, and hypocholesterolemic properties. Bioorganic & Medicinal Chemistry Letters. 16(4). 825–829. 26 indexed citations
12.
Rekka, Eleni A., et al.. (2002). Nitric Oxide in Atherosclerosis. Mini-Reviews in Medicinal Chemistry. 2(6). 585–593. 25 indexed citations
13.
Rekka, Eleni A., et al.. (2002). Cytochrome P450 modification by a new oxazine derivative with hypolipidemic activity.. PubMed. 108(5-6). 325–31. 1 indexed citations
14.
Ellis, S. W., Mark J. Ackland, Eleni A. Rekka, et al.. (1996). Influence of amino acid residue 374 of cytochrome P-450 2D6 (CYP2D6) on the regio- and enantio-selective metabolism of metoprolol. Biochemical Journal. 316(2). 647–654. 57 indexed citations
15.
Rekka, Eleni A., et al.. (1995). The Involvement of Tolfenamic Acid, Mefenamic Acid and Nimesulide in Free Radical Processes. Pharmacy and Pharmacology Communications. 1(10). 483–486. 4 indexed citations
16.
Rekka, Eleni A., et al.. (1995). Novel 1,4 Substituted Piperidine Derivatives. Synthesis and Correlation of Antioxidant Activity with Structure and Lipophilicity. Journal of Pharmacy and Pharmacology. 47(2). 131–137. 10 indexed citations
17.
Kourounakis, Panos N. & Eleni A. Rekka. (1994). Advanced drug design and development : a medicinal chemistry approach. Ellis Horwood eBooks.
18.
Rekka, Eleni A. & Panos N. Kourounakis. (1994). Investigation of the molecular mechanism of the antioxidant activity of some Allium sativum ingredients.. PubMed. 49(7). 539–40. 7 indexed citations
19.
Rekka, Eleni A., et al.. (1994). Synthesis and effect on free radical processes on some substituted morpholine derivatives with potential biologic activity.. PubMed. 44(9). 992–4. 3 indexed citations
20.
Kourounakis, Panos N., et al.. (1991). Effect of the position of the cyano-group of cyanopregnenolones on their drug metabolic inducing activity. European Journal of Drug Metabolism and Pharmacokinetics. 16(1). 9–13. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Panos N. Kourounakis Breakdown of academic impact, for papers by Roberta Budriesi Breakdown of academic impact, for papers by Tadigoppula Narender Breakdown of academic impact, for papers by Rafael Villalobos‐Molina Breakdown of academic impact, for papers by Majid Moridani Breakdown of academic impact, for papers by Zai‐Qun Liu Breakdown of academic impact, for papers by Milan Štefek Breakdown of academic impact, for papers by Lubomı́r Opletal Breakdown of academic impact, for papers by Isabelle Morel Breakdown of academic impact, for papers by Fabio Fusi
Rankless by CCL
2026